Endoscopic vs. conventional radical iliacal lympadenectomy for malignant melanoma - a randomized controlled trial

Not Applicable

Recruiting

• Conditions: C43; Intrapelvic lymph nodes; C77.5; Malignant melanoma of skin

• Registration Number: DRKS00006264
• Lead Sponsor: niversitätsmedizin Berlin - Charité Campus MitteKlinik für Allgemein-, Visceral-, Gefäß- und Thoraxchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

histologically proven inguinal lymph node metastases of an malignant melanoma (biopsy or FNAC)

Exclusion Criteria

previous iliacal surgery or radiation, pregnancy, macrometastases >25mm diameter, impossibility of a complete 30-days-follow-up,
coagulation disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evel of pain at first postoperative day measured with a visual analoge scale

Secondary Outcome Measures

Name	Time	Method
evel of pain at postoperative days 2 til 7 measured with a visual analoge scale, postoperative quality of life at postoperative days 3+7+30 an 12 months after surgery measured with the SF-36 questionnaire, incidence of postoperative wound healing disorders, incidence of local and general complications, incidence and endurrance of postoperative lymphatic fistulas, number of harvested lymph nodes, incidence of local recurrence within one year after surgery